Q&A: The New Standard for Measuring Cough with Tamsin Chislett

Check out the entire Q&A here: www.hyfe.com/insights/q-a...

Adherence is one of the biggest challenges in cough monitoring. Even with the best protocols, poor participant engagement can compromise data before the analysis begins.

Our CEO, Tamsin Chislett, breaks down five practical ways the CoughMonitor Suite improves adherence, without adding friction.

Chronic cough doesn’t just affect the body. It isolates people.

Stories like this remind us why we’re building Hyfe’s digital therapeutic for chronic cough!

🎥 Full Q&A with Reid Moorsmith → www.youtube.com/watch?v=cFCk...
🔗 Learn more: www.hyfe.com/digital-ther...

We look forward to sharing periodic updates as the study progresses and contributes to evidence-based TB control strategies.

Study at a glance:
🟩 Design: Prospective observational study
🧍🏻Recruitment: 100 asymptomatic and 100 clinical TB cases
🗓️ Timeline: 30-month enrollment period plus 12-month follow-up
🎯 Primary objective: Assess incidence of secondary active TB among contacts of asymptomatic index cases

We’re excited to announce TB QUEST: Questioning the Epidemiology of Asymptomatic TB, an observational cohort study enrolling 100 asymptomatic and 100 clinical TB cases over 30 months.

Hyfe will provide continuous cough monitoring to help characterize the full spectrum of TB infection.

Download here: www.hyfe.com/white-papers...

Whose cough are you actually measuring?

In cohabiting settings, that question can make or break data integrity in clinical trials.

We tested a method to attribute cough events—no raw audio, no contact mics, no manual review.

#ClinicalTrials #CoughMonitoring #DigitalHealth #DataIntegrity

Learn about:
✔️ the privacy challenges unique to cough monitoring
✔️ core principles of privacy-by-design in trial technology
✔️ a real-world case study of our privacy-preserving solution in action

Collecting high-quality cough data used to mean compromising on privacy. That’s no longer the case.

If you're still recording audio in clinical trials, it’s time to reassess.

Our latest white paper takes a comprehensive look at the issue and the solution: www.hyfe.com/white-papers...

Monthly Newsletter for Respiratory Health Professionals Monthly newsletter by hyfe.ai, designed for professionals in respiratory research and development. Includes a Research Roundup, Expert Q&As and Interviews, and upcoming events.

📩 The next issue of Cough Science News is out next week. Subscribe now to stay updated on the latest in cough research.

community.hyfe.health/cough-scienc...

In case you missed it: here’s what we highlighted in last month’s Cough Science News.

www.tandfonline.com/doi/full/10....

www.sciencedirect.com/science/arti...

www.tandfonline.com/doi/full/10....

Cough science insights—like never before!

These days at the #ATS2025 meeting in San Francisco have brought an incredible wave of new insights into cough science. It was a busy poster session today, where Peter Small and I shared the latest from @hyfe.com !

We’ve been relying on subjective cough measurement for far too long.

But what happens when one of the most common symptoms in healthcare becomes measurable, objectively, continuously, and passively?

🔊 Listen in: empoweredpatientradio.com/transforming...

Hyfe will be at both the Respiratory Innovation Summit and the @atscommunity.bsky.social #ATS2025!

We’re presenting the world’s first DTx for RCC/UCC, developed with a major Japanese pharma + globally available via CoughPro.

Our CMO, Peter Small, M.D. will also be speaking at the #RIS2025 panel.

Measuring cough has long been a challenge, especially when it comes to the placebo effect.

That’s changing.

Join us April 30 to see what’s now possible with continuous, objective monitoring.

🎙️ Hyfe + ActiGraph

Register below ⬇️

#DigitalHealth #CoughMonitoring #ClinicalTrials #DigitalEndpoints

You can now introduce a clinically relevant, real-time biomarker into your dataset. But why should you?

➡️ Swipe through to explore the value of cough as a health metric combined with other health metrics we track with wearables.

📄 White linked for a deeper dive.

DHM Webinar: The Value of Continuous Cough Monitoring | ActiGraph Explore data-driven health insights with 'Digital Health Monthly' webinar series. Join expert panels to uncover digital health advancements. Register now!

Please join #ActiGraph & @hyfe.com for the upcoming #DigitalHealth Monthly #webinar discussing a new #wearable solution for #cough monitoring in the real world! Don't miss this opportunity to gain insights into cutting-edge #respiratorydisease research.
👉 Register: theactigraph.com/digital-heal...

A recent trial of a stationary, unobtrusive cough monitor showed that:

✅ 59% of exacerbations were flagged by the system

✅ 44% of alerts came before the flare-up started

✅ No patient complaints – in fact, most wanted to keep the device

Can Passive Cough Monitoring Predict COPD Exacerbations? Validation of an alert mechanism for COPD exacerbations based on coughing detected by a stationary unobtrusive nighttime monitor.This prospective double-blind longitudinal study of cough monitoring...

🫁 Can passive cough monitoring predict COPD flare-ups?

New study says: yes – and it can even give a 6-day heads-up.

This is what we’re building toward at Hyfe: passive, accurate, real-world monitoring that supports earlier intervention and better care, without burdening the patient.

Treating Chronic Cough with Digital Therapeutics: Q&A with Tamsin Chislett Hyfe’s CEO discusses the importance of DTx and how it can change the way certain conditions are treated.

Hyfe's CEO Tamsin Chislett recently spoke to @pharmexec.bsky.social about our work to bring digital therapeutics to the frontlines of chronic cough treatment.

We’re thrilled to be featured, and even more excited about what’s ahead.

👀 Curious? Catch the full story here ⬇️

Validation and accuracy of the Hyfe cough monitoring system: a multicenter clinical study - Scientific Reports Scientific Reports - Validation and accuracy of the Hyfe cough monitoring system: a multicenter clinical study

#Digitalhealth tech can transform how we measure symptoms to help researchers capture more accurate, comprehensive, & real-world view of health, including a symptom that is often overlooked & under researched – #cough. Read more in this new paper from @hyfe.com: www.nature.com/articles/s41...

DHM Webinar: The Value of Continuous Cough Monitoring | ActiGraph Explore data-driven health insights with 'Digital Health Monthly' webinar series. Join expert panels to uncover digital health advancements. Register now!

Cough is more than a symptom, it’s a signal.

Join @actigraph.bsky.social's Digital Health Monthly to explore placebo effects, digital cough monitoring, and the future of wearables with Drs. Fan Chung, Peter Small & Christine Guo.
🗓 Apr 30 | 🕛 12pm ET

Want more insights like this? Sign up for our newsletter to stay on top of the latest in cough research, tech breakthroughs, and practice-changing findings.

🔗 community.hyfe.health/cough-scienc...

We're #hiring!

We are seeking a motivated Quality Assurance Specialist to lead quality and compliance across Hyfe's product portfolio. This role offers an exciting opportunity to work at the forefront of AI-powered digital health technology.

See details and apply 👇🏻

Wearables track heart rate, sleep, but miss a vital biomarker: cough. Our whitepaper shows how continuous cough tracking can predict exacerbations, help chronic disease management & power clinical insights ⬇️

www.hyfe.com/white-papers...

💥 Super excited about this milestone - the world’s first prescription digital therapeutic (DTx) for chronic cough is here!!!

@hyfe.com has partnered with KYORIN Pharmaceutical Co., Ltd. to launch this breakthrough in Japan👇

Sounds like your kind of workplace? We’re growing!

Check out our open roles 👋🏻 and join us in redefining how (and where) work happens.

#LifeAtHyfe #RemoteWork #Hiring #FlexibleWork #WorkFromAnywhere